论文部分内容阅读
目的研究分析采用阿司匹林肠溶片联合双嘧达莫治疗脑血栓患者的临床效果。方法选取我院2012年5月~2013年5月在我院确诊收治的74例脑血栓患者,将所有患者随机分为对照组与观察组各37例。对照组患者给予口服阿司匹林肠溶片进行脑血栓常规治疗,观察组在对照组的基础上联合双嘧达莫常规治疗。观察两组患者的临床治疗总有效率,进行对比分析。结果观察组患者的治疗总有效率显著高于对照组,差异显著有统计学意义(P<0.05)。结论采用阿司匹林肠溶片联合双嘧达莫治疗脑血栓患者具有显著的临床应用价值,提高临床效果,改善患者的病情,值得临床大力推广。
Objective To study the clinical effect of aspirin enteric-coated tablets combined with dipyridamole in patients with cerebral thrombosis. Methods A total of 74 patients with cerebral thrombosis admitted to our hospital from May 2012 to May 2013 were randomly divided into control group and observation group, with 37 cases in each group. Patients in the control group were given oral aspirin enteric-coated tablets for routine thrombolytic therapy. The observation group was treated with dipyridamole routinely on the basis of the control group. The total effective rate of clinical treatment in both groups was observed and compared. Results The total effective rate of observation group was significantly higher than that of control group, the difference was statistically significant (P <0.05). Conclusion The aspirin enteric-coated tablets combined with dipyridamole in the treatment of cerebral thrombosis patients have significant clinical value, improve clinical outcomes and improve the patient’s condition, it is worth clinical promotion.